Literature DB >> 24174179

Management of hyperthyroidism in pregnancy.

John H Lazarus1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24174179     DOI: 10.1007/s12020-013-0086-9

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  38 in total

1.  Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.

Authors:  Rebecca S Bahn Chair; Henry B Burch; David S Cooper; Jeffrey R Garber; M Carol Greenlee; Irwin Klein; Peter Laurberg; I Ross McDougall; Victor M Montori; Scott A Rivkees; Douglas S Ross; Julie Ann Sosa; Marius N Stan
Journal:  Thyroid       Date:  2011-04-21       Impact factor: 6.568

2.  The use of antithyroid drugs during pregnancy.

Authors:  E B ASTWOOD
Journal:  J Clin Endocrinol Metab       Date:  1951-10       Impact factor: 5.958

3.  Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring.

Authors:  Dominique Luton; Isabelle Le Gac; Edith Vuillard; Mireille Castanet; Jean Guibourdenche; Michèle Noel; Marie-Elisabeth Toubert; Juliane Léger; Christine Boissinot; Marie-Hélène Schlageter; Catherine Garel; Brigitte Tébeka; Jean-François Oury; Paul Czernichow; Michel Polak
Journal:  J Clin Endocrinol Metab       Date:  2005-08-23       Impact factor: 5.958

4.  Development of primary hypothyroidism with the appearance of blocking-type antibody to thyrotropin receptor in Graves' disease in late pregnancy.

Authors:  Y Ueta; H Fukui; H Murakami; Y Yamanouchi; R Yamamoto; A Murao; Y Santou; S Taniguchi; Y Mitani; C Shigemasa
Journal:  Thyroid       Date:  1999-02       Impact factor: 6.568

5.  The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey.

Authors:  F Aghini-Lombardi; L Antonangeli; E Martino; P Vitti; D Maccherini; F Leoli; T Rago; L Grasso; R Valeriano; A Balestrieri; A Pinchera
Journal:  J Clin Endocrinol Metab       Date:  1999-02       Impact factor: 5.958

Review 6.  Teratogenic and developmental effects of lithium.

Authors:  James J Giles; John G Bannigan
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

7.  Diagnosis and management of Graves' disease in pregnancy.

Authors:  J I Hamburger
Journal:  Thyroid       Date:  1992       Impact factor: 6.568

8.  Fetal loss associated with excess thyroid hormone exposure.

Authors:  João Anselmo; Dingcai Cao; Theodore Karrison; Roy E Weiss; Samuel Refetoff
Journal:  JAMA       Date:  2004-08-11       Impact factor: 56.272

9.  Free T4 immunoassays are flawed during pregnancy.

Authors:  Richard H Lee; Carole A Spencer; Jorge H Mestman; Erin A Miller; Ivana Petrovic; Lewis E Braverman; T Murphy Goodwin
Journal:  Am J Obstet Gynecol       Date:  2008-12-27       Impact factor: 8.661

10.  Characteristics and clinical correlates of a novel thyroid-stimulating autoantibody.

Authors:  M Zakarija; R De Forteza; J M McKenzie; L Ghandur-Mnaymneh
Journal:  Autoimmunity       Date:  1994       Impact factor: 2.815

View more
  3 in total

1.  Associations between thyroid autoantibody status and abnormal pregnancy outcomes in euthyroid women.

Authors:  Liang-Miao Chen; Qian Zhang; Guang-Xin Si; Qing-Shou Chen; En-ling Ye; Le-Chu Yu; Meng-Meng Peng; Hong Yang; Wen-Jun Du; Chi Zhang; Xue-Mian Lu
Journal:  Endocrine       Date:  2014-09-11       Impact factor: 3.633

2.  Pulmonary hypertension in a pregnant patient with thyrotoxicosis due to Graves' disease: considerations with respect to treatment.

Authors:  Vanja Mathot; Erik Oosterwerff; Mariëlle G van Pampus; Robert Riezebos
Journal:  BMJ Case Rep       Date:  2014-02-13

Review 3.  Management of Endocrinopathies in Pregnancy: A Review of Current Evidence.

Authors:  Daniela Calina; Anca Oana Docea; Kirill Sergeyevich Golokhvast; Stavros Sifakis; Aristides Tsatsakis; Antonis Makrigiannakis
Journal:  Int J Environ Res Public Health       Date:  2019-03-04       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.